Peptides, honestly
Peptides for muscle and recovery — what's approved, and what isn't.
Almost every page ranking for these terms is selling something. This one isn't. Here's the actual regulatory status of the compounds people ask us about, what the human evidence looks like, what it means if you compete — and what genuinely moves recovery and muscle, which is far less exciting and far more effective.
What this page is, and what it isn't.
Hammer Fitness coaches training, nutrition and stage presentation. We do not prescribe, supply, source or advise on any medication or research compound — that belongs with a physician who can examine you and read your bloodwork. Nothing here is medical advice or a recommendation to use anything. It's a status summary, because the honest version is hard to find and people deserve it before they spend money.
First, a correction
Half of what gets called a peptide isn't one
"Peptide" has become a marketing word covering several unrelated categories, which is convenient for anyone selling and unhelpful for everyone else.
- Peptides are short chains of amino acids. Insulin is a peptide. So is semaglutide. So is BPC-157.
- SARMs are not peptides. Ostarine, LGD-4033 and RAD-140 are selective androgen receptor modulators — small molecules that act on the androgen receptor. Different class entirely, routinely sold under the same "peptides" banner.
- Anabolic steroids are not peptides either, and in Canada most are controlled substances under the CDSA.
- Being a peptide says nothing about being safe or legal. It's a description of chemistry, not a status.
If a vendor lists all three under one heading, that tells you something about the vendor.
The short list
What's actually approved
Very little, and none of it for building muscle.
| Compound | Status | Approved for |
|---|---|---|
| Semaglutide, tirzepatide | Approved | Type 2 diabetes and weight management. Prescription only. |
| Tesamorelin (Egrifta) | Approved | Excess abdominal visceral fat in HIV-associated lipodystrophy — that one indication only. Prescription only. |
| Retatrutide | Investigational | Nothing. Phase 3 trials. No prescribing pathway anywhere. |
| BPC-157 | Unapproved | Nothing, in any country. |
| TB-500 / thymosin beta-4 | Unapproved | Nothing, in any country. |
| CJC-1295, ipamorelin, MK-677 and similar | Unapproved | Nothing. Growth hormone secretagogues, none approved for muscle building. |
| Ostarine, LGD-4033, RAD-140 | Unapproved | Nothing. SARMs, not peptides, subject to regulator warnings. |
Status as at 2026 and subject to change — regulatory positions on several of these have moved more than once this year. Verify current status before relying on anything here.
Notice what's missing from the approved column. There is no approved peptide for building muscle. Not one, anywhere in the world.
Every compound marketed for that purpose is unapproved, which means no manufacturing standards, no verified dose, and no completed human efficacy trial establishing it does what the sales page claims.
The two most asked about
BPC-157 and TB-500, in plain terms
These are what people mean when they search "peptides for pain" or "peptides for healing." Here's where they actually stand.
Neither is approved anywhere
Not by the FDA, not by the EMA, not by Health Canada, for any indication. The FDA placed BPC-157 in Category 2 of the 503A bulk substances list in 2023 — a classification reflecting identified safety concerns — then removed it, along with eleven other peptides, on 15 April 2026.
That removal is being widely misread as approval. It isn't. It's a change to compounding classification with further rulemaking still in progress. Nothing about it makes either compound an approved drug, and nothing about it creates a legal consumer supply route.
The human evidence is thinner than people assume
A 2025 systematic review in the HSS Journal found BPC-157's evidence base consisted of 35 preclinical animal studies and a single uncontrolled 16-patient chart review. There is no published human pharmacokinetic data, and its plasma half-life is under 30 minutes.
That isn't "early but promising." That's an absence of the human research that would tell you whether it works, at what dose, or what it does over years.
If you compete in a tested federation, read this part twice.
BPC-157 has been explicitly named on the WADA Prohibited List under Section S0 — Non-Approved Substances — since 1 January 2022. TB-500 is likewise prohibited at all times. No Therapeutic Use Exemption is available for either, because a TUE requires an approved therapeutic indication and neither has one.
The Canadian Centre for Ethics in Sport has sanctioned an athlete with four years of ineligibility for BPC-157 and TB-500. That is a career, for a compound with one uncontrolled human chart review behind it.
What "research use only" actually means
Products sold under that label carry it so the seller isn't making a drug claim. The practical consequences are the same every time: no pharmaceutical manufacturing controls, no verified purity, no sterility assurance, no confirmed dose. What's in the vial is whatever was in the vial. If something goes wrong, there is no recourse and no recall.
The part that works
What actually drives recovery and muscle
Unglamorous, well evidenced, and almost always the thing that hasn't been done properly before someone starts researching compounds.
Enough load, not too much
Muscle grows in response to mechanical tension, and adaptation flattens past a point where extra volume only adds fatigue. Most people are either under-loading or accumulating junk volume. The dose–response curve →
More than you're eating
The single most protective nutritional variable for lean mass. Most people arrive eating roughly half of what supports the training they're doing — and no compound compensates for that.
The recovery nobody optimises
Growth hormone release is largely tied to slow-wave sleep. People chasing secretagogues to raise GH are frequently sleeping six broken hours, which is the intervention actually available to them.
Here's the pattern we see, over and over.
Someone researching recovery compounds is usually training too often, eating too little protein, sleeping badly, and progressing too fast for their connective tissue. Fix those four and recovery improves — measurably, in weeks, at no legal or health risk.
If they're still not resolved after that, the next appointment is with a physician. Not a vendor.
Where we can help is the part that isn't in dispute. Training built for what you can recover from, nutrition written with portion sizes rather than macro targets, and programming that respects the fact connective tissue adapts slower than muscle. More on how that works on our personal training page, on training around an injury, and — for anyone using approved weight-loss medication — on keeping muscle on GLP-1s.
Questions
Common questions
Are any peptides approved for building muscle?
No. There is no peptide approved anywhere in the world for building muscle. Semaglutide and tirzepatide are approved for diabetes and weight management, and tesamorelin is approved for excess abdominal visceral fat in HIV-associated lipodystrophy, but nothing is approved for muscle growth. Every compound marketed for that purpose is unapproved.
Is BPC-157 legal?
BPC-157 is not approved by the FDA, EMA, Health Canada or any other regulator for any indication. The FDA placed it in Category 2 of the 503A bulk drug substances list in 2023 and removed it on 15 April 2026, but that is a compounding classification change rather than approval, with further rulemaking in progress. There is no legal consumer supply route.
Is TB-500 the same as BPC-157?
No. TB-500 is a synthetic fragment of thymosin beta-4; BPC-157 derives from a protein found in gastric juice. They have different sequences and different proposed mechanisms. Both are unapproved for human use and both are prohibited in sport.
Are BPC-157 and TB-500 banned in sport?
Yes, at all times. BPC-157 has been explicitly named on the WADA Prohibited List under Section S0, Non-Approved Substances, since 1 January 2022, and TB-500 is likewise prohibited. No Therapeutic Use Exemption is available for either, because a TUE requires an approved therapeutic indication and neither has one. The Canadian Centre for Ethics in Sport has issued a four-year ineligibility sanction for their use.
What does 'research use only' mean on a peptide vial?
It means the seller is not making a drug claim, which keeps them outside pharmaceutical regulation. The practical result is no manufacturing controls, no verified purity or sterility, and no confirmed dose. There is no recourse if the contents are not what the label says.
Are SARMs peptides?
No. Ostarine, LGD-4033 and RAD-140 are selective androgen receptor modulators, a different class of compound entirely. They are frequently sold alongside peptides under the same heading, which is a marketing decision rather than a chemical one. None are approved for human use and all are prohibited in sport.
Do you advise clients on peptides?
No. Hammer Fitness coaches training, nutrition and stage presentation. We do not prescribe, supply, source or advise on any medication or research compound. Those decisions belong with a physician who can examine you and monitor your bloodwork, and we are glad to build training around whatever they advise.
What actually improves recovery?
Training volume set to what you can recover from, adequate protein, sufficient sleep, and progression paced to connective tissue rather than enthusiasm. Most people researching recovery compounds have not yet addressed those four, and fixing them produces measurable improvement within weeks at no legal or health risk.
Get Started
Fix the free stuff first.
Training, protein and recovery, built properly around your schedule. Free consultation, no obligation, and a straight answer about what's actually limiting you.
This page is general information about the regulatory status of certain compounds and about training and nutrition. It is not medical advice and is not a recommendation to use any substance. Hammer Fitness does not prescribe, supply, source or advise on any medication or research compound. Regulatory status changes — several positions referenced here shifted during 2026 and remain subject to ongoing rulemaking. Verify current status independently and consult a licensed physician before considering any medication.
